Evidence map›Paper›PMID 41847440›Full record

SynthesisFrontiers in cellular and infection microbiology2026

Probiotic cell-free supernatants as a strategy against antimicrobial resistance: a systematic review.

Maisah Meyhr D'Carmo Sodré, Ian David Araújo Cruz, Uener Ribeiro Santos, Sheila Cristina Potente Dutra Luquetti, Vânia Lúcia Silva, Alessandra Barbosa Ferreira Machado, Cláudio Galuppo Diniz, Cláudio Teodoro de Souza, Carla Cristina Romano, Lauro Juliano Marin and 1 more

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Isolation andFrontiers in microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maisah Meyhr D'Carmo SodréDepartment of Biological Sciences, Microbiology Laboratory, Santa Cruz State University, Ilhéus, Bahia, Brazil.
Ian David Araújo CruzDepartment of Biological Sciences, Microbiology Laboratory, Santa Cruz State University, Ilhéus, Bahia, Brazil.
Uener Ribeiro SantosAges Faculty of Medicine of Irecê, Biomedicine Collegiate, Irecê, Bahia, Brazil.
Sheila Cristina Potente Dutra LuquettiNutrition Faculty, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Vânia Lúcia SilvaInstitute of Biological Sciences at Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Alessandra Barbosa Ferreira MachadoInstitute of Biological Sciences at Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Cláudio Galuppo DinizInstitute of Biological Sciences at Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Cláudio Teodoro de SouzaFaculty of Medicine, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Carla Cristina RomanoDepartment of Biological Sciences, Microbiology Laboratory, Santa Cruz State University, Ilhéus, Bahia, Brazil.
Lauro Juliano MarinHealth Department, Santa Cruz State University, Ilhéus, Bahia, Brazil.
Luciana Debortoli de CarvalhoPostgraduate Program in Biology and Biotechnology of Microorganisms, Microbiology Laboratory, Santa Cruz State University, Ilhéus, Bahia, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a critical global health threat that may cause up to 10 million deaths annually by 2050, requiring integrated actions within the One Health framework. The misuse of antimicrobials across human, animal, and environmental sectors has intensified the spread of multidrug-resistant bacteria, including

Indexed as

Anti-Bacterial AgentsBacteriaDrug Resistance, BacterialDrug Resistance, Multiple, BacterialLactobacillusProbioticsAnimalsBiofilmsHumansAnti-Bacterial Agentsalternative therapiesantimicrobial resistancecell free supernatantone healthsystematic review

Identifiers

PMID41847440
PMCPMC12989548

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.